Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terrence A Barrett

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The American Journal of Pathology|May 10, 2016
Epithelial PIK3R1 (p85) and TP53 Regulate Survivin Expression during Adaptation to Ileocecal ResectionValeria Cohran, Elizabeth Managlia, Emily M Bradford, et al.
Gastroenterology|June 29, 2010
Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitisGoo Lee, Tatiana Goretsky, Elizabeth Managlia, et al.
Therapeutic Advances in Gastroenterology|November 2, 2020
Ustekinumab dose escalation improves clinical responses in refractory Crohn's diseaseSyedreza A Haider, Abhijeet Yadav, Courtney Perry, et al.
Plos One|May 22, 2013
TLR4 activates the β-catenin pathway to cause intestinal neoplasiaRebeca Santaolalla, Daniel A Sussman, Jose R Ruiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2017
Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel DiseaseEmily M Bradford, Stacy H Ryu, Ajay Pal Singh, et al.
The American Journal of Gastroenterology|January 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter ExperienceJeffrey A Berinstein, Taylor Karl, Anish Patel, et al.
Pharmaceutics|April 26, 2025
The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience ProgramStephen B Hanauer, Esther A Torres, Patricia Aragon-Han, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The American Journal of Pathology|May 10, 2016
Epithelial PIK3R1 (p85) and TP53 Regulate Survivin Expression during Adaptation to Ileocecal ResectionValeria Cohran, Elizabeth Managlia, Emily M Bradford, et al.
Gastroenterology|June 29, 2010
Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitisGoo Lee, Tatiana Goretsky, Elizabeth Managlia, et al.
Therapeutic Advances in Gastroenterology|November 2, 2020
Ustekinumab dose escalation improves clinical responses in refractory Crohn's diseaseSyedreza A Haider, Abhijeet Yadav, Courtney Perry, et al.
Plos One|May 22, 2013
TLR4 activates the β-catenin pathway to cause intestinal neoplasiaRebeca Santaolalla, Daniel A Sussman, Jose R Ruiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2017
Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel DiseaseEmily M Bradford, Stacy H Ryu, Ajay Pal Singh, et al.
The American Journal of Gastroenterology|January 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter ExperienceJeffrey A Berinstein, Taylor Karl, Anish Patel, et al.
Pharmaceutics|April 26, 2025
The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience ProgramStephen B Hanauer, Esther A Torres, Patricia Aragon-Han, et al.
Pageof 7